Xeris Biopharma Holdings, Inc. XERS
9.10
0.15
1.68%
as of 25 Sep
- Market cap
- $1.6B
- P/E
- 0.0×
Follow XERS
Growth Flags
show if company had growth for consecutive years
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
2,065.79 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
4.32 | 2.45 | 1.91 | 1.38 | 4.67 | 10.27 | 67.63 | 84.52 | 0.00 | 0.00 |
P/FCF ratio |
45.09 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
62.83 | 251.93 | 41.83 | (9.42) | (8.00) | (19.30) | (6.22) | (11.17) | (5.62) | (5.62) |
P/B ratio |
92.00 | 0.00 | 0.00 | 3.36 | 2.43 | 6.21 | 12.75 | 2.72 | 0.00 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6.21 | 12.75 | 2.72 | 0.00 | 0.00 |
EV/Sales |
4.73 | 3.24 | 2.64 | 1.98 | 4.44 | 8.13 | 62.39 | 51.19 | 0.00 | 0.00 |
EV/EBITDA |
33.70 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
48.23 | (17.79) | (9.22) | (2.12) | (2.30) | (2.06) | (1.63) | (2.20) | (0.36) | (0.36) |
EV/FCF |
49.43 | (17.39) | (8.79) | (2.11) | (2.28) | (2.05) | (1.61) | (2.15) | (0.35) | (0.35) |
Quick Ratio |
1.48 | 1.12 | 1.17 | 2.08 | 1.52 | 4.99 | 2.94 | 11.35 | 8.90 | 12.81 |
Current Ratio |
2.19 | 1.67 | 1.64 | 2.54 | 1.80 | 5.40 | 3.20 | 11.59 | 9.06 | 13.13 |
Net Debt/EBITDA |
2.67 | (8.91) | (4.14) | (0.98) | 0.13 | 0.58 | 0.14 | 1.38 | 1.59 | 2.46 |
Debt/Assets |
57.45% | 71.85% | 59.19% | 54.76% | 28.94% | 54.68% | 53.50% | 26.57% | 0.00% | 0.00% |
Debt/Equity |
16.10 | (7.84) | (28.15) | 4.18 | 0.92 | 2.58 | 4.04 | 0.42 | 0.00 | 0.00 |
Asset Turnover |
0.83 | 0.63 | 0.49 | 0.34 | 0.21 | 0.15 | 0.02 | 0.03 | 0.04 | 0.03 |
Operating CF/Net income |
51.67 | 0.67 | 0.76 | 1.09 | 0.78 | 0.88 | 0.83 | 0.94 | 0.93 | 1.22 |
Capex/Depreciation |
(0.04) | (0.06) | (0.15) | (0.04) | (0.38) | (0.15) | (0.55) | (1.72) | (3.11) | (0.30) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (6.96%) | 301.32% | (324.20%) | (134.83%) | (190.28%) | (378.20%) | (279.56%) | (683.66%) | 59.16% | 29.43% | |
| 0.16% | (16.99%) | (18.66%) | (29.18%) | (52.95%) | (67.98%) | (109.67%) | (72.81%) | (67.63%) | (33.64%) | |
ROIC |
12.65% | (16.07%) | (24.63%) | (45.78%) | (89.00%) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
0.41% | (75.34%) | (92.86%) | (79.74%) | (174.86%) | (69.73%) | (184.68%) | (54.74%) | (66.42%) | (42.67%) |
Average Days of Receivables |
63.85 | 72.64 | 87.28 | 102.07 | 128.48 | 122.80 | 629.30 | 432.19 | 281.26 | 34.29 |
Research and Development Expense of Revenue |
10.68% | 12.59% | 13.63% | 19.02% | 50.74% | 102.38% | 2,220.35% | 1,677.84% | 1,296.02% | 952.37% |
Selling, General and Administrative Expense of Revenue |
62.49% | 80.50% | 89.13% | 124.94% | 253.51% | 360.81% | 2,316.72% | 871.36% | 515.10% | 377.67% |
Intangible Assets out of Total Assets |
0.29 | 0.38 | 0.41 | 0.42 | 0.51 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
7.66% | 9.04% | 6.54% | 11.03% | 22.95% | 40.48% | 238.21% | 71.32% | 32.07% | 50.23% |
Graham Net Nets |
(0.10) | (0.37) | (0.55) | (0.74) | (0.29) | 0.13 | (0.04) | 0.36 | 0.76 | 0.76 |
Graham Number |
0.09 | 1.31 | 0.71 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
0.05% | (11.21%) | (19.82%) | (62.50%) | (51.88%) | (46.34%) | (68.09%) | (60.28%) | (9.55%) | (9.55%) |
Free Cash Flow Yield |
2.22% | (7.61%) | (15.77%) | (68.08%) | (41.73%) | (38.58%) | (57.29%) | (28.22%) | (76.34%) | (76.34%) |
Revenue per Share |
1.82 | 1.38 | 1.19 | 0.81 | 0.63 | 0.48 | 0.10 | 0.20 | 0.77 | 0.58 |
Operating CF per Share |
0.18 | (0.25) | (0.34) | (0.76) | (1.21) | (1.89) | (4.00) | (4.67) | (12.16) | (8.73) |
Capex per Share |
0.00 | (0.01) | (0.02) | 0.00 | (0.01) | (0.01) | (0.04) | (0.13) | (0.35) | (0.02) |
Free Cash Flow per Share |
0.17 | (0.26) | (0.36) | (0.76) | (1.22) | (1.90) | (4.04) | (4.80) | (12.51) | (8.75) |
Cash per Share |
0.69 | 0.49 | 0.53 | 0.90 | 1.30 | 3.14 | 2.89 | 9.35 | 20.73 | 17.52 |
Shareholders Equity per Share |
0.09 | (0.20) | (0.05) | 0.33 | 1.21 | 0.79 | 0.55 | 6.26 | 19.75 | 16.81 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.09 | (0.20) | (0.05) | 0.33 | 1.21 | 0.79 | 0.55 | 6.26 | 19.75 | 16.81 |
Free Cash Flow |
27.93 | (37.85) | (49.29) | (103.41) | (96.62) | (80.93) | (105.45) | (57.79) | (25.36) | (16.12) |
Working Capital |
130.74 | 67.22 | 61.07 | 113.20 | 63.56 | 124.01 | 60.15 | 107.73 | 39.19 | 30.65 |
Capital Expenditures |
(0.70) | (0.87) | (2.26) | (0.52) | (1.08) | (0.38) | (1.11) | (1.51) | (0.70) | (0.03) |
Net Current Asset Value |
(129.52) | (185.01) | (173.12) | (112.52) | (66.53) | 26.82 | (7.07) | 73.28 | 39.10 | 30.61 |
EV/EBIT |
55.45 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 0.00 | 0.01 | 0.00 | 0.02 | 0.02 | 0.41 | 0.62 | 0.45 | 0.03 |
Net Profit Margin |
0.19% | (27.00%) | (37.98%) | (85.86%) | (247.48%) | (446.00%) | (4,613.52%) | (2,479.57%) | (1,706.56%) | (1,228.74%) |
Price to Operating Income |
50.58 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
3.25 | 2.81 | 2.57 | 2.58 | 0.43 | 0.36 | 0.26 | 0.43 | 0.29 | 0.37 |
Cash ROIC |
6.86% | (15.52%) | (20.65%) | (30.47%) | (35.75%) | (34.28%) | (75.66%) | (26.51%) | (31.00%) | (25.93%) |
Accounts Receivable Turnover |
6.38 | 5.10 | 4.68 | 4.57 | 4.08 | 3.53 | 0.72 | 1.19 | 2.39 | 1.65 |
Accounts Payable Turnover |
15.87 | 5.32 | 3.54 | 3.35 | 2.21 | 2.14 | 0.50 | 0.23 | 0.00 | 0.00 |
Inventory Turnover |
0.73 | 0.85 | 0.90 | 1.06 | 1.01 | 1.77 | 0.30 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
26.37 | 22.69 | 147.36 | 74.28 | 244.58 | 121.97 | 1,275.79 | 987.78 | 180,310.00 | 59,996.88 |
Days of Inventory on Hand |
588.82 | 477.41 | 494.88 | 398.88 | 496.55 | 326.85 | 495.47 | 0.00 | 0.00 | 0.00 |
Average Receivables |
45.73 | 39.81 | 35.01 | 24.14 | 12.17 | 5.78 | 3.78 | 2.03 | 0.65 | 0.65 |
Average Payables |
2.68 | 6.93 | 8.09 | 6.77 | 6.02 | 4.36 | 3.23 | 1.42 | 1.65 | 1.65 |
Average Inventory |
58.42 | 43.51 | 31.79 | 21.43 | 13.24 | 5.26 | 5.26 | — | — | — |
Average Assets |
353.29 | 322.83 | 333.56 | 324.44 | 231.76 | 134.07 | 114.51 | 82.51 | 39.27 | 39.27 |
Average Common Equity |
(7.96) | (18.20) | 19.20 | 70.21 | 64.50 | 24.10 | 44.92 | 8.79 | (44.88) | (44.88) |
Columns are period end dates